1887

Abstract

Kaposi’s sarcoma-associated herpesvirus (KSHV) has been associated with the development of Kaposi’s sarcoma (KS), primary effusion lymphoma (PEL), and multicentric Castleman’s disease. Cytogenetic studies have revealed chromosome abnormalities in KS tissues, including recurring copy number changes in chromosomes and the loss of chromosomes. Unfaithful DNA repair may contribute to the genomic instability that is one of the most common hallmarks of tumours. We found that lytic infection of KSHV can cause severe DNA double-strand breaks (DSBs) and impair non-homologous end joining (NHEJ) in host cells. Processivity factor 8 (PF-8) of KSHV was identified as interacting with Ku70 and Ku86, and the interaction was dependent on DSBs and DNA. Overexpression of PF-8 in HeLa cells impaired NHEJ by blocking the interaction between the Ku complex and the DNA-dependent protein kinase catalytic subunit. These results suggest that KSHV lytic replication may contribute to tumorigenesis by causing DNA DSBs and interfering with the repair of DSBs.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/vir.0.053033-0
2013-08-01
2022-05-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/94/8/1870.html?itemId=/content/journal/jgv/10.1099/vir.0.053033-0&mimeType=html&fmt=ahah

References

  1. Ablashi D. V., Chatlynne L. G., Whitman J. E. Jr, Cesarman E. 2002; Spectrum of Kaposi’s sarcoma-associated herpesvirus, or human herpesvirus 8, diseases. Clin Microbiol Rev 15:439–464 [View Article][PubMed]
    [Google Scholar]
  2. An J., Sun Y., Fisher M., Rettig M. B. 2004; Antitumor effects of bortezomib (PS-341) on primary effusion lymphomas. Leukemia 18:1699–1704 [View Article][PubMed]
    [Google Scholar]
  3. Burma S., Chen B. P., Chen D. J. 2006; Role of non-homologous end joining (NHEJ) in maintaining genomic integrity. DNA Repair (Amst) 5:1042–1048 [View Article][PubMed]
    [Google Scholar]
  4. Casper C. 2005; The aetiology and management of Castleman disease at 50 years: translating pathophysiology to patient care. Br J Haematol 129:3–17 [View Article][PubMed]
    [Google Scholar]
  5. Chen X., Lin K., Ricciardi R. P. 2004; Human Kaposi’s sarcoma herpesvirus processivity factor-8 functions as a dimer in DNA synthesis. J Biol Chem 279:28375–28386 [View Article][PubMed]
    [Google Scholar]
  6. Chronowski G. M., Ha C. S., Wilder R. B., Cabanillas F., Manning J., Cox J. D. 2001; Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92:670–676 [View Article][PubMed]
    [Google Scholar]
  7. Deriano L., Guipaud O., Merle-Béral H., Binet J. L., Ricoul M., Potocki-Veronese G., Favaudon V., Maciorowski Z., Muller C.& other authors ( 2005; Human chronic lymphocytic leukemia B cells can escape DNA damage-induced apoptosis through the nonhomologous end-joining DNA repair pathway. Blood 105:4776–4783 [View Article][PubMed]
    [Google Scholar]
  8. Fowler R. A., Meyskens F. L. Jr 1978; Tumor viruses and human cancer. II. DNA tumor viruses. Ariz Med 35:661–662, 666–667[PubMed]
    [Google Scholar]
  9. Gaspar M., Shenk T. 2006; Human cytomegalovirus inhibits a DNA damage response by mislocalizing checkpoint proteins. Proc Natl Acad Sci U S A 103:2821–2826 [View Article][PubMed]
    [Google Scholar]
  10. Gholam D., Vantelon J. M., Al-Jijakli A., Bourhis J. H. 2003; A case of multicentric Castleman’s disease associated with advanced systemic amyloidosis treated with chemotherapy and anti-CD20 monoclonal antibody. Ann Hematol 82:766–768 [View Article][PubMed]
    [Google Scholar]
  11. Green M., Wold W. S. 1976; Oncogenic DNA viruses–replication, tumor gene expression, and role in human cancer. Semin Oncol 3:65–79[PubMed]
    [Google Scholar]
  12. Hayward G. S. 2003; Initiation of angiogenic Kaposi’s sarcoma lesions. Cancer Cell 3:1–3 [View Article][PubMed]
    [Google Scholar]
  13. Herrada J., Cabanillas F., Rice L., Manning J., Pugh W. 1998; The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128:657–662 [View Article][PubMed]
    [Google Scholar]
  14. Jenner R. G., Albà M. M., Boshoff C., Kellam P. 2001; Kaposi’s sarcoma-associated herpesvirus latent and lytic gene expression as revealed by DNA arrays. J Virol 75:891–902 [View Article][PubMed]
    [Google Scholar]
  15. Jha H. C., Upadhyay S. K., Aj M. P., Lu J., Cai Q., Saha A., Robertson E. S. 2013; H2AX phosphorylation is important for LANA-mediated Kaposi’s sarcoma-associated herpesvirus episome persistence. J Virol 87:5255–5269 [View Article][PubMed]
    [Google Scholar]
  16. Kao J., Rosenstein B. S., Peters S., Milano M. T., Kron S. J. 2005; Cellular response to DNA damage. Ann N Y Acad Sci 1066:243–258 [View Article][PubMed]
    [Google Scholar]
  17. Kudoh A., Fujita M., Zhang L., Shirata N., Daikoku T., Sugaya Y., Isomura H., Nishiyama Y., Tsurumi T. 2005; Epstein–Barr virus lytic replication elicits ATM checkpoint signal transduction while providing an S-phase-like cellular environment. J Biol Chem 280:8156–8163 [View Article][PubMed]
    [Google Scholar]
  18. Kumari P., Schechter G. P., Saini N., Benator D. A. 2000; Successful treatment of human immunodeficiency virus-related Castleman’s disease with interferon-alpha. Clin Infect Dis 31:602–604 [View Article][PubMed]
    [Google Scholar]
  19. Lord C. J., Ashworth A. 2012; The DNA damage response and cancer therapy. Nature 481:287–294 [View Article][PubMed]
    [Google Scholar]
  20. Mladenov E., Kalev P., Anachkova B. 2009; The complexity of double-strand break ends is a factor in the repair pathway choice. Radiat Res 171:397–404 [View Article][PubMed]
    [Google Scholar]
  21. Nair P., Pan H., Stallings R. L., Gao S. J. 2006; Recurrent genomic imbalances in primary effusion lymphomas. Cancer Genet Cytogenet 171:119–121 [View Article][PubMed]
    [Google Scholar]
  22. Nishimoto N., Kanakura Y., Aozasa K., Johkoh T., Nakamura M., Nakano S., Nakano N., Ikeda Y., Sasaki T.& other authors ( 2005; Humanized anti-interleukin-6 receptor antibody treatment of multicentric Castleman disease. Blood 106:2627–2632 [View Article][PubMed]
    [Google Scholar]
  23. Pan H., Zhou F., Gao S. J. 2004; Kaposi’s sarcoma-associated herpesvirus induction of chromosome instability in primary human endothelial cells. Cancer Res 64:4064–4068 [View Article][PubMed]
    [Google Scholar]
  24. Pastwa E., Błasiak J. 2003; Non-homologous DNA end joining. Acta Biochim Pol 50:891–908[PubMed]
    [Google Scholar]
  25. Pastwa E., Neumann R. D., Mezhevaya K., Winters T. A. 2003; Repair of radiation-induced DNA double-strand breaks is dependent upon radiation quality and the structural complexity of double-strand breaks. Radiat Res 159:251–261 [View Article][PubMed]
    [Google Scholar]
  26. Popescu N. C., Zimonjic D. B., Leventon-Kriss S., Bryant J. L., Lunardi-Iskandar Y., Gallo R. C. 1996; Deletion and translocation involving chromosome 3 (p14) in two tumorigenic Kaposi’s sarcoma cell lines. J Natl Cancer Inst 88:450–455 [View Article][PubMed]
    [Google Scholar]
  27. Pyakurel P., Montag U., Castaños-Vélez E., Kaaya E., Christensson B., Tönnies H., Biberfeld P., Heiden T. 2006; CGH of microdissected Kaposi’s sarcoma lesions reveals recurrent loss of chromosome Y in early and additional chromosomal changes in late tumour stages. AIDS 20:1805–1812 [View Article][PubMed]
    [Google Scholar]
  28. Rogakou E. P., Pilch D. R., Orr A. H., Ivanova V. S., Bonner W. M. 1998; DNA double-stranded breaks induce histone H2AX phosphorylation on serine 139. J Biol Chem 273:5858–5868 [View Article][PubMed]
    [Google Scholar]
  29. Seluanov A., Mittelman D., Pereira-Smith O. M., Wilson J. H., Gorbunova V. 2004; DNA end joining becomes less efficient and more error-prone during cellular senescence. Proc Natl Acad Sci U S A 101:7624–7629 [View Article][PubMed]
    [Google Scholar]
  30. Shirata N., Kudoh A., Daikoku T., Tatsumi Y., Fujita M., Kiyono T., Sugaya Y., Isomura H., Ishizaki K., Tsurumi T. 2005; Activation of ataxia telangiectasia-mutated DNA damage checkpoint signal transduction elicited by herpes simplex virus infection. J Biol Chem 280:30336–30341 [View Article][PubMed]
    [Google Scholar]
  31. Thompson S. L., Compton D. A. 2011; Chromosomes and cancer cells. Chromosome Res 19:433–444 [View Article][PubMed]
    [Google Scholar]
  32. Valladares Y. 1967; Cancerigenic viruses neoformed in in vitro cultured cells starting on DNA from human cancer cells. Med Pharmacol Exp Int J Exp Med 16:311–324[PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/vir.0.053033-0
Loading
/content/journal/jgv/10.1099/vir.0.053033-0
Loading

Data & Media loading...

Most cited this month Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error